ESC Premium Access

Performance of the HAS-BLED, ATRIA, and PRECISE-DAPT Bleeding Risk Scores in Atrial Fibrillation Patients Using Antiplatelet Agents or Oral Anticoagulants

Presentation

About the speaker

Mr Jin Young Choi

Busan (Korea (Republic of))
0 follower

9 more presentations in this session

Dabigatran versus vitamin K antagonists in patients with atrial fibrillation and valvular heart disease

Speaker: Doctor J. Strange (Copenhagen, DK)

Thumbnail

Comparing the effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in the elderly asian patients with atrial fibrillation

Speaker: Doctor T. Chao (Taipei, TW)

Thumbnail

Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis

Speaker: Mrs A. Kang (Lawrenceville, US)

Thumbnail

Comparative safety of factor-xa inhibitors vs phenprocoumon in patients with non-valvular atrial fibrillation and renal disease - insights from the RELOADED study

Speaker: Professor H. Bonnemeier (Kiel, DE)

Thumbnail

Risk prediction of atrial fibrillation in the community combining biomarkers and genetics

Speaker: Doctor C. Boerschel (Hamburg, DE)

Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 6

Speakers: Mr J. Choi, Doctor J. Strange, Doctor T. Chao, Mrs A. Kang, Professor H. Bonnemeier...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk